Filter
534
Filtered Results: 534
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
182
Guidelines
129
Studies & Reports
123
Manuals
39
Fact sheets
25
Strategic & Response Plan
24
Situation Updates
8
Training Material
3
Resource Platforms
1
Countries / Regions
Global
23
India
21
Latin America and the Carribbean
20
Africa
17
Brazil
12
Nigeria
9
Kenya
9
Western and Central Europe
9
South Africa
8
Russia
8
Colombia
7
Middle East and North Africa
7
Liberia
6
Uganda
6
Germany
6
Namibia
6
West and Central Africa
6
Sierra Leone
5
Zambia
5
East and Southern Africa
5
Venezuela
5
Western Pacific Region
4
Eastern Europe and Central Asia
4
USA
3
Ghana
3
Zimbabwe
3
Philippines
3
Syria
3
Tanzania
3
Rwanda
3
Mozambique
3
Angola
3
Guinea
2
Burkina Faso
2
Congo, Democratic Republic of
2
Cameroon
2
Pakistan
2
Bangladesh
2
Malawi
2
Peru
2
Bolivia
2
Chile
2
Yemen
2
South–East Asia Region
2
Eastern Europe
2
Tajikistan
2
France
2
Senegal
1
Guinea-Bissau
1
Ethiopia
1
Haiti
1
Nepal
1
South Sudan
1
Jordan
1
Afghanistan
1
Turkey
1
Cambodia
1
Indonesia
1
Sudan
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Ukraine
1
Ecuador
1
Lesotho
1
Myanmar / Burma
1
Asia
1
Southern Africa
1
Vietnam
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
145
Clinical Guidelines
60
Public Health
27
Pharmacy & Technologies
20
Key Resources
11
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
58
AMR
52
NTDs
38
HIV
20
TB
19
Pharmacy
18
Mental Health
17
Ebola
16
Planetary Health
15
Zika
12
NCDs
9
Cholera
6
Disability
5
Caregiver
5
Refugee
4
Specific Hazards
4
Conflict
3
Natural Hazards
3
Polio
2
Global Health Education
2
Health Financing Toolbox
2
The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se...
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Infection Prevention and Control Programmes
January 2020
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Revised and expanded version of the Guidelines
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Le syndrome respiratoire aigu provoqué par le coronavirus-2 (SARS-CoV-2), initialement décrit en Chine, est responsable
de la pandémie que nous connaissons actuellement sous le nom de coronavirus disease 2019 ou COVID-19. L'épidémie de
coronavirus a été déclarée « urgence de santé publi...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
A review of current literature and up date data from the field, April 2015.
This report has been published in part in J Hosp Inf. 2015;90:1-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...
